Similarly, Akram et al. found that CCRL2 knockdown had mild effects on the proliferation and survival of prostate cancer cells [22], while Wang et al. showed that CCRL2 overexpression suppressed breast cancer cell growth both in vitro and in vivo [34]. Here, CCRL2 is linked to prostate carcinoma.